Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOCUSATE\SENNOSIDES A AND B Cause Affect lability? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Affect lability have been filed in association with DOCUSATE\SENNOSIDES A AND B. This represents 5.1% of all adverse event reports for DOCUSATE\SENNOSIDES A AND B.

8
Reports of Affect lability with DOCUSATE\SENNOSIDES A AND B
5.1%
of all DOCUSATE\SENNOSIDES A AND B reports
0
Deaths
2
Hospitalizations

How Dangerous Is Affect lability From DOCUSATE\SENNOSIDES A AND B?

Of the 8 reports, 2 (25.0%) required hospitalization.

Is Affect lability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOCUSATE\SENNOSIDES A AND B. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does DOCUSATE\SENNOSIDES A AND B Cause?

Somnolence (52) Gastrooesophageal reflux disease (37) Coma (35) Pneumonia aspiration (35) Fatigue (25) Constipation (23) Off label use (21) Cardiomyopathy (20) Fall (18) Pyrexia (18)

What Other Drugs Cause Affect lability?

DULOXETINE (2,510) METFORMIN (291) AMLODIPINE (274) METHOTREXATE (266) ATORVASTATIN (259) IRBESARTAN (257) LEVOTHYROXINE (251) SITAGLIPTIN (244) ESOMEPRAZOLE (234) ASPIRIN (224)

Which DOCUSATE\SENNOSIDES A AND B Alternatives Have Lower Affect lability Risk?

DOCUSATE\SENNOSIDES A AND B vs DOFETILIDE DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR\LAMIVUDINE DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR\RILPIVIRINE

Related Pages

DOCUSATE\SENNOSIDES A AND B Full Profile All Affect lability Reports All Drugs Causing Affect lability DOCUSATE\SENNOSIDES A AND B Demographics